Developing the epithelial, viral, and allergic paradigm for asthma: Giles F. Filley lecture

Chest

Volumn 123, Issue 3 SUPPL., 2003, Pages 377S-384S

  Holtzman, Michael J ^a   Agapov, Eugene ^a   Kim, Edy ^a   Kim, Joo In ^a   Morton, Jeffrey D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 9; LIPID; PEPTIDE; PROTEINASE; RANTES; RNA; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ATOPY; B LYMPHOCYTE; BRONCHIOLITIS; BRONCHITIS; CELL ADHESION; CELL FUNCTION; CELL HYPERPLASIA; CELL INTERACTION; CELL MIGRATION; CHEMOTAXIS; CHRONICITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE PREDISPOSITION; EOSINOPHIL; EPITHELIUM CELL; GENE EXPRESSION; GENETIC POLYMORPHISM; GOBLET CELL; HOST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; MEDIATOR; MUCUS; NONHUMAN; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; PARENCHYMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENDAI VIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS GENE; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0037338486     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.3_suppl.377s-a     Document Type: Conference Paper

References (48)

1. Holtzman MJ, Look DC, Iademarco MF, et al. In: Jameson JL, ed. Principles of molecular medicine. Totawa, NJ: Humana Press, 1998; 319-327
2. Finotto S, Neurath NF, Glickman JN, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295:336-338
3. Gavett SH, O'Hearn DJ, Li X, et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995; 182:1527-1536
4. Lack G, Bradley KL, Hamelmann E, et al. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 1996; 157:1432-1439
5. Sur S, Wild JS, Choudhury BK, et al. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999; 162:6284-6293
6. Kay AB. Allergy and allergic diseases. N Engl J Med 2001; 344:30-37
7. Ober C, Moffatt MF. Contributing factors to the pathobiology: the genetics of asthma. Clin Chest Med 2000; 21:245-261
8. Bandeira-Melo C, Herbst A, Weller PF. Eotaxins: contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 2001; 24:653-657
9. Grayson MH, Holtzman MJ. Lessons from allergic rhinitis versus asthma pathogenesis and treatment. Immunol Allergy Clin North Am 2002; 22:845-869
10. Willliams CMM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192:455-462
11. Hansen G, Berry G, DeKruyff R, et al. Allergen-specific Th1 cells fail to counterbalanee Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-183
12. Randolph DA, Stephens R, Carruthers CJL, et al. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104:1021-1029
13. Hogan SP, Mould A, Kikutani H, et al. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997; 99:1329-1339
14. Melhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997; 94:1344-1349
15. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-2261
16. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183:109-117
17. Foster PS, Hogan SP, Ramsay AJ, et al. IL-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1995; 183:195-201
18. Holtzman MJ, Sampath D, Castro M, et al. The one-two of T helper cells: does interferon-γ knockout the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol 1996; 14:316-318
19. Hakonarson H, Bjornsdottir US, Ostermann E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001; 164:2036-2044
20. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med 1996; 183:1-5
21. Holtzman MJ, Morton JD, Shornick LP, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev 2002; 82:19-46
22. Koga T, Sardina E, Tidwell RM, et al. Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization. Proc Natl Acad Sci USA 1999; 96:5680-5685
23. Look DC, Roswit WT, Frick AG, et al. Direct suppression of Stat1 function during adenoviral infection. Immunity 1998; 9:871-880
24. Sampath D, Castro M, Look DC, et al. Constitutive activation of an epithelial signal transducer and activator of transcription (Stat1) pathway in asthma. J Clin Invest 1999; 103:1353-1361
25. Taguchi M, Sampath D, Koga T, et al. Patterns for RANTES secretion and intercellular adhesion molecule-1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med 1998; 187:1927-1940
26. Walter MJ, Kajiwara N, Karanja P, et al. IL-12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001; 193:339-352
27. Nakajima S, Look DC, Roswit WT, et al. Selective differences in vascular endothelial- vs. airway epithelial-T cell adhesion mechanisms. Am J Physiol 1994; 267:L422-L432
28. + yγ T cell adherence and tissue retention. J Immunol 1995; 155:1117-1131
29. Holtzman MJ, Castro M, Look DC, et al. Regulation of epithelial-leukocyte interaction and epithelial immune-response genes. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Cambridge, MA: Blackwell Scientific, 2000; 784-800
30. Look DC, Keller BT, Rapp SR, et al. Selective induction of intercellular adhesion molecule-1 by interferon-γ in human airway epithelial cells. Am J Physiol 1992; 263:L79-L87
31. Look DC, Pelletier MR, Holtzman MJ. Selective interaction of a subset of interferon-γ response element binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem 1994; 269:8952-8958
32. Look DC, Pelletier MR, Tidwell RM, et al. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 1995; 270:30264-30267
33. Walter MJ, Look DC, Tidwell RM, et al. Targeted inhibition of interferon-γ-dependent ICAM-1 expression using dominant-negative Stat1. J Biol Chem 1997; 272:28582-28589
34. Walter MJ, Holtzman MJ. Epithelial production of IL-12 p80 during viral Infection and asthma supports an altered paradigm for airway inflammation. In: Eissa NT, Huston DP, eds. Biology of airway inflammation: therapeutic targets, lung biology in health and disease. New York, NY: Marcel Dekker, 2002; 535-562
35. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 1999; 12:298-309
36. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med 2001; 163:S2-S6
37. Graham BS, Perkins MD, Wright PF, et al. Primary respiratory syncytial virus infection in mice. J Med Virol 1988; 26:153-162
38. Walter MJ, Morton JD, Kajiwara N, et al. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002; 110:165-175
39. Nevels M, Tauber B, Spruss T, et al. "Hit and run" transformation by adenovirus oncogenes. J Virol 2001; 75:3089-3094
40. Shen Y, Zhu H, Shenk T. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit and run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 1997; 94:3341-3345
41. Coyle AJ, Tsuyuki S, Bertrand C, et al. Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol 1996; 156:2680-2685
42. Vanacker JJ, Palmans E, Kips JC, et al. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 2001; 163:674-679
43. + T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001; 166:1813-1822
44. + T cells that persist in the lungs. J Exp Med 2001; 193:981-986
45. + cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995; 181:1229-1233
46. Schwarze J, Cieslewicz G, Joetham A, et al. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999; 162:4207-4211
47. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 1997; 186:421-432
48. Ashwell JD, Lu FWM, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000; 18:309-345